Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128707) titled 'Application of Oliceridine Combined with Ciprofol in Painless Gastrointestinal Endoscopy: A Randomized Controlled Trial' on July 24.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Liuzhou people's hospital
Condition:
digestive system diseases
Intervention:
Control group (Group S1):Improved up-and-down sequential method: initial Sufentanil dose 0.1 µg/kg with a ratio of 1:1.1
Experimental group:Group O2: Ciprofol + Oliceridine ED95
Experimental group (Group O1):Improved up-and-down sequential method, initial dose of Oliceridine 10 µg/kg at a 1:1.2 ratio
Recruitment Stat...